My 10 Top Stocks to Buy to Start the New Year Off Right


Investors scored big wins last year as the S&P 500, the Nasdaq, and the Dow Jones Industrial Average all climbed by double digits. Investor enthusiasm about technology and growth stocks, and the economic environment ahead, drove the momentum.

Right now, it’s too early to predict with 100% certainty whether the indexes will deliver yet another annual gain, but there are reasons to be optimistic about the possibility. After all, the artificial intelligence (AI) growth story is in its early days, and the Federal Reserve has launched interest rate cuts. These elements could support stock performance in the year ahead.

But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most importantly over the long term. Here are my top 10 buys, with this list offering you the great combination of growth and security, to start the new year off right.

2025 is written on a starting line for a race with a focus on a person's feet in sneakers.
Image source: Getty Images.

Eli Lilly (NYSE: LLY) is the maker of one of today’s most in-demand treatments: weight loss drugs. Lilly makes tirzepatide, sold under the name Zepbound for weight loss and Mounjaro for type 2 diabetes. These products have quickly become blockbusters, bringing in billions of dollars in revenue.

On top of that, Lilly has scored two recent victories. Regulators declared tirzepatide no longer is in shortage, meaning compounding pharmacies no longer can produce their versions and take market share from Lilly. And second, Lilly won approval for Zepbound in sleep apnea along with obesity — and that helped it recently secure Medicare coverage for the drug when prescribed for the sleep apnea indication.

Goldman Sachs Research forecasts the obesity drug market may reach as much as $130 billion by 2030, Bloomberg reported, and Lilly is well positioned to benefit from this growth.

Meta Platforms (NASDAQ: META) is a leader in the world of social media as owner of Facebook, Messenger, Instagram, and WhatsApp. And this has helped the company generate billions of dollars in advertising revenue year after year.

Today, Meta continues to dominate in social media and on top of this the company is investing heavily in AI. The idea is to build AIs that all users can benefit from — and as they spend even more time on Meta’s apps, advertisers may invest even more in advertising here to reach them. Meta’s work in AI also may generate other compelling products and services over time.

All of this makes now a great time to get in on this top tech player.

Salesforce (NYSE: CRM), a leader in the customer relationship management software space, has proved its revenue strength over the long term. Now, it’s heading for a new growth opportunity that may be huge, and that’s agentic AI. This is the creation of AI software, or agents, to analyze complex problems and apply solutions.



Source link

About The Author

Scroll to Top